I was going to mention that they have about $300m in cash and bullion, so yeah $1.5b EV makes this super compelling to me right now.
As I said, I love NST, but I sold most of my shares in them as I believe this has suffered more in the near term, and should bounce back harder, unless there is something major we don't know about as people are speculating - but I doubt it.
If a couple of my slow burn, under performers can come good in the next couple of weeks, and this is still down, I will be selling them and buying this.
In saying that, I'm reluctant to be too overweight in a company that is still falling.
As for the numbers, I think they have shifted a bit since the original announcements.
As per D&D
- 170k - 200k per annum
- Infra and Plant - $350 - $400m (almost doubled from the numbers above!)
- AISC $1100 - $1200 over the life of mine (you were on the money)
McPs DFS due any time now, they were hoping to finish it in August, but that has come and gone.
As for a potential sale, what would we do with $800m in the bank? What or who would you recommend we buy?
Unless there was something that was equally long life but with major synergies that we could jump into straight away that would offer faster returns than building out McPs, we would probably get punished for not putting the capital to work fast enough.
Anything is possible in these crazy times.
One thing I am confident of is this company is going to fly once we get our first real quarter of full production across Duketon and Tropicana. Probably 6 months away.
It's a 12 month hold to get the CGT discount, so might as well start the clock now hey!
The D&D presentation about McPs if anyone else wanted a refresher.
- Forums
- ASX - By Stock
- RRL
- Under valued
RRL
regis resources limited
Add to My Watchlist
2.23%
!
$4.39

Under valued, page-192
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.39 |
Change
-0.100(2.23%) |
Mkt cap ! $3.316B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.37 | $16.81M | 3.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 7201 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | 4.350 |
4 | 7325 | 4.300 |
1 | 1174 | 4.270 |
2 | 1435 | 4.250 |
1 | 2700 | 4.240 |
Price($) | Vol. | No. |
---|---|---|
4.420 | 5266 | 1 |
4.550 | 1000 | 1 |
4.570 | 222 | 1 |
4.580 | 6000 | 1 |
4.610 | 180 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online